P53 integrity in the genetically engineered mammalian cell lines AHH-1 and MCL-5

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 423, Issue 1-2, 1999, Pages 39-46

  Guest, Ryan D ^a   Parry, James M ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

AHH 1; Cell death; MCL 5; MNNG; Mutation; p53

Indexed keywords

LIPOCORTIN 5; PROTEIN P53; RESTRICTION ENDONUCLEASE;

ARTICLE; CELL CULTURE; CELL DEATH; CODON; CONTROLLED STUDY; DNA DAMAGE; EXON; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ENGINEERING; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MAMMAL CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; ANNEXIN A5; BASE SEQUENCE; CELL DEATH; CELL LINE, TRANSFORMED; DNA MUTATIONAL ANALYSIS; GENETIC ENGINEERING; HUMANS; LYMPHOCYTES; METHYLNITRONITROSOGUANIDINE; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTAGENS; RESTRICTION MAPPING; TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA;

EID: 0033601834     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00223-1     Document Type: Article

References (26)

1. C. Crofton-Sleigh, A.T. Doherty, S. Ellard, E.M. Parry, V. Venitt, Micronucleus assays using cytochalasin-blocked MCL-5 cells, a proprietary human cell line expressing five human cytochromes P-450 and microsomal epoxide hydrolase, Mutagenesis 8 (1993) 363-373.
2. W. Busby Jr., W. Penman, C. Crespi, Human cell mutagenicity of mono- and dinitropyrenes in metabollicaly competent MCL-5 cells, Mutation Res. 322 (1994) 233-242.
3. C. Crespi, F. Gonzalez, D. Steimel, T. Turner, H. Gelboin, B. Penman, R. Langenbach, A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing, Chem. Res. Toxicol. 4 (1991) 566-572.
4. S. Morris, O. Domon, L. McGarrity, J. Chen, M. Manjanatha, A. Andrews, A. Aidoo, D. Casciano, A role for apoptosis in the toxicity and mutagenicity of bleomycin in AHH-1 tk + /- human lymphoblastoid cells, Mutation Res. 357 (1996) 143-165.
5. S. Morris, M. Manjanatha, S. Shelton, O. Domon, L. McGarrity, D. Casciano, A mutation in the p53 tumor suppressor gene of AHH-1 tk( +/-) human lymphoblastoid cells, Mutation Res. 356 (1996) 129-134.
6. C. Prives, How loops, beta sheets, and alpha helices help us to understand p53, Cell 78 (1994) 543-546.
7. Y. Cho, S. Gorina, P. Jeffrey, N. Pavletich, Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumourigenic mutations, Science 265 (1994) 346-355.
8. M. Hollstein, D. Sidransky, B. Vogelstein, C. Harris, p53 Mutations in human cancers, Science 253 (1991) 49-53.
9. J. Nigro, S. Baker, A. Preisinger, J. Milburn Jessup, R. Hostetter, K. Cleary, S. Bigner, N. Davidson, S. Baylin, P. Devilee, T. Glover, F. Collins, A. Weston, R. Modali, C. Harris, B. Vogelstein, Mutations in the p53 gene occur in diverse human tumor types, Nature 342 (1989) 705-708.
10. T. Takahashi, M. Nau, I. Chiba, M. Birrer, R. Rosenberg, M. Vinocour, M. Levitt, H. Pass, A. Gazdar, J. Minna, p53: a frequenl largel for genelic abnormalilies in lung cancer, Science 246 (1989) 491-494.
11. S. Lowe, E. Schmitt, S. Smith, B. Osborne, T. Jacks, p53 is required for radiation-induced apoptosis in mouse thymocyles, Nature 362 (1993) 847-849.
12. A. Clarke, C. Purdie, D. Harrison, R. Morris, C. Bird, M. Hooper, A. Wyllie, Thymocyte apoplosis induced by p53-dependent and independent pathways, Nature 362 (1993) 849-852.
13. V. Fadok, D. Voelker, P. Campbell, J. Cohen, D. Bratton, P. Henson, Exposure to phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages, J. Immunology 148 (1992) 2207-2216.
14. V. Fadok, J. Savill, C. Haslett, D. Bratton, D. Doherty, P. Campbell, P. Henson, Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognise and remove apoptotic cells, J. Immunology 149 (1992) 4029-4035.
15. V. Fadok, D. Laszio, P. Noble, L. Weinstein, D. Riches, P. Henson, Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells, J. Immunology 151 (1993) 4274-4285.
16. G. Koopman, C. Reutelingsperger, G. Kuijten, R. Keehnen, S. Pais, M. van Oers, Annexin-V for flow cytometric detection of phospohtidylserine expression on B-cells undergoing apoptosis, Blood 84 (1994) 1415-1420.
17. C. Homburg, M. de Hass, A. von dem Borne, A. Verhoeven, C. Reutelingsperger, D. Roos, Human neutrophiles lose their surface FC-gamma-RIII and aquire annexin-V binding-sites during apoptosis in vitro, Blood 85 (1995) 532-540.
18. S. Martin, C. Reutelinsperger, A. McGahon, J. Rader, R. Vanschie, D. Laface, D. Green, Early redistribution of plasma-membrane phosphotidylserine is a general feature of apoptosis regardless of the initiating stimulus-inhibition by overexpression of BCL-2 and ABL, J. Exp. Med. 182 (1995) 1545-1556.
19. L. Crespi, W. Thilly, Assay for gene mutation in a human lymphoblast cell line, AHH-1, competent for xenobiotic metabolism, Mutation Res. 128 (1984) 221-230.
20. R.L. Davies, C.L. Crespi, K. Rudo, T. Turner, R. Lagenbach, Development of a human cell line by selection and drug-metabolizing gene transfection with increased capacity to activate promutagens, Carcinogenesis 10 (1989) 885-892.
21. S. Miller, D. Dykes, H. Polesky, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res. 16 (1988) 1215-1215.
22. D. Slamenova, A. Gabelova, L. Ruzekoza, I. Chalupa, E. Horvathova, T. Farkasova, E. Bozakyova, R. Stetina, Detection of MNNG-induced DNA lesions in mammalian cells; validation of comet of DNA unwinding technique, alkaline elution of DNA and chromosomal aberrations, Mutation Res. 383 (1997) 243-252.
23. Y. Tominaga, T. Tsuzuki, A. Shiraishi, H. Kawate, M. Sekiguchi, Alkylation-induced apoptosis of embryonic stem cells in which the gene for DNA-repair, methyltransferase, had been disrupted by gene targeting, Carcinogenesis 18 (1997) 889-896.
24. S. Morris, L. McGarrity, O. Domon, J. Chen, D. Casciano, Programmed cell death and mutation induction in AHH-1 human lymphoblastoid cells exposed to m-amsa, Mutation Res. 329 (1995) 79-96.
25. J. Ribeiro, J. Hanley, P. Russell, Studies of X-ray irradiated bladder cancer cell lines showing differences in p53 status: absence of a p53-dependent cell cycle check point pathway, Oncogene 13 (1996) 1269-1278.
26. J. Adachi, K. Ookawa, M. Shiseki, T. Okazaki, S. Tsuchida, K. Morishita, J. Yokota, Induction of apoptosis but not Gl arrest by expression of the wild-type p53 gene in small lung cell carcinoma, Cell Growth Development 7 (1996) 879-886.